Peter Frampton Cancels 2024 Tour Following Sudden Diagnosis of Rare Muscle Disease
NEW YORK, NY — May 15, 2024 — Rock and Roll Hall of Famer Peter Frampton has abruptly cancelled his remaining 2024 tour dates after being diagnosed with inclusion body myositis, a rare and progressive muscle disease that has significantly impaired his ability to perform. The 74-year-old guitarist, best known for the iconic live album "Frampton Comes Alive!," announced the decision via a formal statement released through his management team earlier today, citing irreversible deterioration in his motor skills and grip strength. Medical experts confirm that inclusion body myositis, which has no known cure, leads to chronic inflammation and weakness in skeletal muscles, affecting fine motor movements essential for playing guitar. Frampton, who first disclosed his condition in 2019, had previously characterized it as a challenge but continued to tour with adaptations. During a press conference held in Manhattan, his physician, Dr. Sarah Chen of the Mayo Clinic, stated that recent scans revealed a rapid acceleration of muscle fiber degeneration, making further performances medically inadvisable. Concert venues in Chicago, London, and Sydney, where Frampton was scheduled to headline, will issue full refunds to ticketholders. The announcement has sparked widespread online discussion, with fans and fellow musicians expressing support, while industry analysts at Billboard note that this represents a significant loss for the 2024 live music circuit, as Frampton had been a top-grossing legacy act. Authorities have not reported any criminal activity, and no legal disputes have emerged from the cancellation.